Arrowhead Pharmaceuticals (ARWR) EBITDA Margin Growth (5y) (2015 - 2026)
Arrowhead Pharmaceuticals (ARWR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,553.00 |
| Dec 31, 2025 | 12,837.00 |
| Sep 30, 2025 | 67,382.00 |
| Jun 30, 2025 | -53,796.00 |
| Mar 31, 2025 | 16,476.00 |
| Dec 31, 2024 | -644,000.00 |
| Dec 31, 2023 | -387,684.00 |
| Sep 30, 2023 | -57,375.00 |
| Jun 30, 2023 | 153,966.00 |
| Mar 31, 2023 | 234,542.00 |
| Dec 31, 2022 | 32,620.00 |
| Sep 30, 2022 | -14,786.00 |
| Jun 30, 2022 | -16,378.00 |
| Mar 31, 2022 | 9,559.00 |
| Dec 31, 2021 | 11,059.00 |
| Sep 30, 2021 | 6.96 Mn |
| Jun 30, 2021 | 4.88 Mn |
| Mar 31, 2021 | 4.85 Mn |
| Dec 31, 2020 | 4.41 Mn |
| Sep 30, 2020 | 5.70 Mn |